胶质母细胞瘤的 CAR-T 细胞治疗:克服当前障碍与提升疗效的策略及其治疗意义
Chimeric antigen receptor T cell therapy for glioblastoma: overcoming current barriers and strategies to enhance efficacy for therapeutic implications
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Chimeric antigen receptor T cell therapy for glioblastoma: overcoming current barriers and strategies to enhance efficacy for therapeutic implications
CAR-T cell therapy for glioblastoma: insight from mathematical modeling.
本研究提出了一个针对胶质母细胞瘤 CAR-T 细胞治疗的综合性建模框架,强调了给药方案和耐药动态的重要性。研究结果为优化治疗策略以改善患者预后提供了有价值的指导。
CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future.
Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma.
Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings.
MEMBER ACCOUNT
登录成功会直接打开下一页。